IL10 and systemic lupus erythematosus: The overall results showed decreases in the plasma concentrations of ANA and anti-dsDNA antibody in the LZ–SMS-treated SLE mice (Fig. 3), indicating that the suppressive activity of LZ–SMS would be not only limited to CD4+ Treg cells, but also related to the propagation of IL-10+ Breg cells.